vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and GREENE COUNTY BANCORP INC (GCBC). Click either name above to swap in a different company.
GREENE COUNTY BANCORP INC is the larger business by last-quarter revenue ($22.2M vs $13.8M, roughly 1.6× FENNEC PHARMACEUTICALS INC.). GREENE COUNTY BANCORP INC runs the higher net margin — 46.3% vs -34.7%, a 81.1% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 23.8%). Over the past eight quarters, GREENE COUNTY BANCORP INC's revenue compounded faster (18.9% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.
FENC vs GCBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $22.2M |
| Net Profit | $-4.8M | $10.3M |
| Gross Margin | — | — |
| Operating Margin | -18.5% | 52.0% |
| Net Margin | -34.7% | 46.3% |
| Revenue YoY | 73.8% | 23.8% |
| Net Profit YoY | -141.1% | 37.4% |
| EPS (diluted) | $-0.17 | $0.60 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $22.2M | ||
| Q3 25 | $12.5M | $21.5M | ||
| Q2 25 | $9.7M | $20.5M | ||
| Q1 25 | $8.8M | $20.1M | ||
| Q4 24 | $7.9M | $17.9M | ||
| Q3 24 | $7.0M | $16.9M | ||
| Q2 24 | $7.3M | $16.6M | ||
| Q1 24 | $25.4M | $15.7M |
| Q4 25 | $-4.8M | $10.3M | ||
| Q3 25 | $-638.0K | $8.9M | ||
| Q2 25 | $-3.2M | $9.3M | ||
| Q1 25 | $-1.2M | $8.1M | ||
| Q4 24 | $-2.0M | $7.5M | ||
| Q3 24 | $-5.7M | $6.3M | ||
| Q2 24 | $-5.6M | $6.7M | ||
| Q1 24 | $12.8M | $5.9M |
| Q4 25 | -18.5% | 52.0% | ||
| Q3 25 | -1.5% | 47.4% | ||
| Q2 25 | -28.3% | 53.5% | ||
| Q1 25 | -9.2% | 44.6% | ||
| Q4 24 | -11.8% | 45.0% | ||
| Q3 24 | -74.6% | 39.6% | ||
| Q2 24 | -69.4% | 41.2% | ||
| Q1 24 | 54.2% | 39.4% |
| Q4 25 | -34.7% | 46.3% | ||
| Q3 25 | -5.1% | 41.2% | ||
| Q2 25 | -32.7% | 45.6% | ||
| Q1 25 | -13.3% | 40.1% | ||
| Q4 24 | -25.0% | 41.7% | ||
| Q3 24 | -82.2% | 37.1% | ||
| Q2 24 | -76.5% | 40.6% | ||
| Q1 24 | 50.6% | 37.3% |
| Q4 25 | $-0.17 | $0.60 | ||
| Q3 25 | $-0.02 | $0.52 | ||
| Q2 25 | $-0.11 | $0.55 | ||
| Q1 25 | $-0.04 | $0.47 | ||
| Q4 24 | $-0.02 | $0.44 | ||
| Q3 24 | $-0.21 | $0.37 | ||
| Q2 24 | $-0.20 | $0.39 | ||
| Q1 24 | $0.41 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.5M | $258.3M |
| Total Assets | $70.6M | $3.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | — | ||
| Q3 25 | $21.9M | — | ||
| Q2 25 | $18.7M | — | ||
| Q1 25 | $22.7M | $155.5M | ||
| Q4 24 | $26.6M | $166.4M | ||
| Q3 24 | $40.3M | — | ||
| Q2 24 | $43.1M | $190.4M | ||
| Q1 24 | $51.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | — | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $35.5M | $258.3M | ||
| Q3 25 | $-4.5M | $248.2M | ||
| Q2 25 | $-7.5M | $238.8M | ||
| Q1 25 | $-5.9M | $229.0M | ||
| Q4 24 | $-5.9M | $218.4M | ||
| Q3 24 | $-5.2M | $216.3M | ||
| Q2 24 | $-1.4M | $206.0M | ||
| Q1 24 | $3.0M | $199.2M |
| Q4 25 | $70.6M | $3.1B | ||
| Q3 25 | $49.3M | $3.1B | ||
| Q2 25 | $44.9M | $3.0B | ||
| Q1 25 | $46.4M | $3.0B | ||
| Q4 24 | $44.9M | $3.0B | ||
| Q3 24 | $58.9M | $2.9B | ||
| Q2 24 | $63.2M | $2.8B | ||
| Q1 24 | $69.2M | $2.9B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $6.4M |
| Free Cash FlowOCF − Capex | — | $6.2M |
| FCF MarginFCF / Revenue | — | 28.0% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 0.62× |
| TTM Free Cash FlowTrailing 4 quarters | — | $47.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $6.4M | ||
| Q3 25 | $1.5M | $7.0M | ||
| Q2 25 | $-3.7M | $28.0M | ||
| Q1 25 | $-4.3M | $7.3M | ||
| Q4 24 | $-1.5M | $5.3M | ||
| Q3 24 | $-2.2M | $2.1M | ||
| Q2 24 | $-8.4M | $24.9M | ||
| Q1 24 | $39.0M | $5.6M |
| Q4 25 | — | $6.2M | ||
| Q3 25 | — | $6.5M | ||
| Q2 25 | — | $27.3M | ||
| Q1 25 | — | $7.3M | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | — | $2.0M | ||
| Q2 24 | — | $23.4M | ||
| Q1 24 | — | $4.9M |
| Q4 25 | — | 28.0% | ||
| Q3 25 | — | 30.4% | ||
| Q2 25 | — | 133.3% | ||
| Q1 25 | — | 36.1% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 11.8% | ||
| Q2 24 | — | 141.2% | ||
| Q1 24 | — | 31.3% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 9.1% | ||
| Q1 24 | — | 4.2% |
| Q4 25 | — | 0.62× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 3.00× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 0.71× | ||
| Q3 24 | — | 0.34× | ||
| Q2 24 | — | 3.70× | ||
| Q1 24 | 3.04× | 0.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
